insights_auto
Why is ORX down 2.85%?
Dive Deeperchevron_right
ORX:STO
Orexo AB
SEKÂ 0.85
arrow_downward
-2.85%(-0.025) 1D
Nov 16, 9:04:36 AM GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
SEKÂ 0.89
High
SEKÂ 0.89
Low
SEKÂ 0.85
Mkt. cap
298.26M
Avg. vol.
777.72K
Volume
75.44K
P/E ratio
0.06
52-wk high
SEKÂ 22.55
52-wk low
SEKÂ 0.80
EPS
SEKÂ 13.61
Shares outstanding
35.13M
No. of employees
55
Open
SEKÂ 0.89
High
SEKÂ 0.89
Low
SEKÂ 0.85
Mkt. cap
298.26M
Avg. vol.
777.72K
Volume
75.44K
P/E ratio
0.06
52-wk high
SEKÂ 22.55
52-wk low
SEKÂ 0.80
EPS
SEKÂ 13.61
Shares outstanding
35.13M
No. of employees
55
News stories
From web sources and news partners
Yahoo Finance
·
22 minutes ago
The S&P 500 Looks Cheaper Than It Has in Over 3 Years, but There’s a Catch
Investing.com
·
40 minutes ago
Bulls See S&P 500 Hitting 7,900 by Year-End as Earnings and Valuations Improve
Yahoo Finance
·
1 hour ago
Stock Market: Will S&P 500 Open Up or Down Today?
The Motley Fool
·
13 hours ago
This Dividend King Yields 5 Times the S&P 500. Is It a Buy Now?
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB
CEONikolaj Sørensen
Employees55
Founded1995
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteorexo.com